According to a research report titled ‘Asia Pacific Advanced Wound Care Market Size, By Application, By Product, By End-use, Research Report, Country Outlook, Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 – 2027’, available with Market Study Report, Asia Pacific advanced wound care market is projected to amass a valuation of USD 2.6 billion by the end of the forecast period 2021-2027.
 

As per the report findings, rising number of surgical procedures, increasing geriatric population, and pervasiveness of chronic wounds are stimulating APAC advanced wound care market growth. Moreover, the market uptake of advanced wound care has been growing in the backdrop of technological advancements in the form of lower healing time and efficient wound management.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3580803/
 

Despite the positive industry outlook, high costs of medical devices is likely to pose as major challenge for business operating in this domain.
 

Based on product type, the market is categorized into wound dressings (anti-microbial, hydrogel, alginate, film, foam, hydrocolloidal, others), wound therapy devices (pressure relief, electrostimulation, negative pressure wound therapy systems, oxygen & hyperbaric oxygen equipment) and others.
 

The market share from wound dressings segment is slated expand at a CAGR of 5% over 2021-2027. This can be credited to surging investments in antimicrobial, alginate, and foam dressings, perceivable rise in number of road accidents, and easy accessibility of wound dressings.
 

By application scope, the industry is classified into diabetic wounds, pressure wounds, venous leg ulcers, surgical wounds, skin burns, and others. The venous leg ulcers segment is expected to register a robust CAGR of 14.5% through 2027. Dressings and surgeries are considered to be a viable treatment option for venous leg ulcers, thus fueling segmental expansion. On the other hand, skin burn segment accounted for over 25% market share in 2020 and is estimated to grow at a healthy rate through 2027, owing to the prevalence of skin burns in developing economies.
 

Moving on to end-user scope, the research literature classifies Asia pacific advanced wound care market into homecare settings, hospitals, and others. The hospitals segment share is slated to expand at a CAGR of 5% through 2027, owing to availability of advanced equipment, increasing cases of chronic and acute wounds, and presence of well-trained healthcare professionals.
 

On the regional front, India advanced wound care industry is projected to exhibit 6.5% CAGR over the forecast period, owing to inflow of investments, and rise in elderly population in the region. Meanwhile, Japan market was valued at USD 480 million in 2020 and is slated to grow considerably through 2027, due to sharp rise in wound care research.
 

Prominent players in Asia Pacific advanced wound care industry sphere are Smith & Nephew plc, Organogenesis Inc., Mölnlycke Health Care AB, Medtronic plc, Medline Industries Inc., Integra LifeSciences Corp., Hollister Inc., Hartmann International GmbH & Co. KG, Coloplast Corp., ConvaTec Group plc, Beiersdorf AG, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, and 3M Company.